Patents matching “vaccine”

WO 2026104630

MÉTHODE DE SÉLECTION DOMINANTE PERMANENTE POUR LA GÉNÉRATION DU VIRUS ANKARA DE LA VACCINE MODIFIÉ RECOMBINANT (MVA)

BAVARIAN NORDIC AS [DK] · Granted May 21, 2026 · Expires May 16, 2046

WO 2025238219

VIRUS MODIFIÉ DE LA VACCINE ANKARA (MVA) CODANT POUR DES NANOPARTICULES PROTÉIQUES PRÉSENTANT DES ANTIGÈNES

BAVARIAN NORDIC AS [DK] · Granted Nov 20, 2025 · Expires Nov 15, 2045

US 12419941

Poultry drinking water-based vaccine delivery system and method

The United States of America, as represented by the Secretary of Agriculture · Granted Sep 23, 2025 · Expires Sep 18, 2045

US 12409213

Live attenuated oral vaccine against shigellosis and typhoid fever

Sanaria Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

US 12409220

Conjugate polypeptides and vaccines for inducing immune responses

The Regents of the University of California · Granted Sep 9, 2025 · Expires Sep 4, 2045

US 12404533

Bioconjugate vaccines' synthesis in prokaryotic cell lysates

Northwestern University · Granted Sep 2, 2025 · Expires Aug 28, 2045

US 12370255

Peptide-based vaccines, methods of manufacturing, and uses thereof for inducing an immune response

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Jul 29, 2025 · Expires Jul 24, 2045

US 12364745

Immunogenicity of a CpG-adjuvanted recombinant plague vaccine

The Government of the United States, as represented by the Secretary of the Army · Granted Jul 22, 2025 · Expires Jul 17, 2045

US 12357687

Compositions and vaccines for treating and/or preventing viral infections, and methods of using the same

EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 15, 2025 · Expires Jul 10, 2045

US 12357682

DNA plasmid-launched live-attanuated vaccines for plus-sense singel stranded RNA

The Board of Regents of the University of Texas System · Granted Jul 15, 2025 · Expires Jul 10, 2045

US 12343388

Clostridioides difficile TcdB variants, vaccines and methods of use

The Board of Regents of the University of Oklahoma · Granted Jul 1, 2025 · Expires Jun 26, 2045

US 12285478

Foot-and-mouth disease vaccine

United States of America as represented by the Secretary of the Air Force · Granted Apr 29, 2025 · Expires Apr 24, 2045

US 12285473

Cancer vaccines targeting MUC16 and uses thereof

Inovio Pharmaceuticals, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

US 12286456

Purification of virus like particles

Takeda Vaccines, Inc. · Granted Apr 29, 2025 · Expires Apr 24, 2045

US 12280108

Vaccines having an antigen and interleukin-21 as an adjuvant

Inovio Pharmaceuticals, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

US 12274741

Cattle fever tick-infestation vaccines and uses thereof

The United States of America, as represented by the Secretary of Agriculture · Granted Apr 15, 2025 · Expires Apr 10, 2045

US 12269155

Multivalent vaccines for rabies virus and coronaviruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

US 12258372

Recombinant vaccine against Marek's disease and Newcastle disease

The United States of America, as represented by the Secretary of Agriculture · Granted Mar 25, 2025 · Expires Mar 20, 2045

US 12257302

Universal vaccine platform

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Mar 25, 2025 · Expires Mar 20, 2045

US 12240872

Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

Inovio Pharmaceuticals, Inc. · Granted Mar 4, 2025 · Expires Feb 27, 2045

US 12234263

Influenza vaccines

The Regents of the University of California · Granted Feb 25, 2025 · Expires Feb 20, 2045

US 12233119

Composition for oral or nasal delivery of tetanus, diphtheria, and pertussis vaccine alone or in combination using neurotoxin associated proteins

Prime Bio, Inc. · Granted Feb 25, 2025 · Expires Feb 20, 2045

US 12220455

Coronavirus vaccine compositions and methods

ARCTURUS THERAPEUTICS, INC. · Granted Feb 11, 2025 · Expires Feb 6, 2045

US 12201683

Methods for preventing dengue and hepatitis a

Takeda Vaccines, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045